Clinical Trial: Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

Brief Summary: To survey the grade of gastric MALT lymphoma after eradication of Helicobacter pylori

Detailed Summary:
Sponsor: Eisai Co., Ltd.

Current Primary Outcome:

• Response rate of gastric low-grade MALT lymphoma by eradication of Helicobacter pylori [ Time Frame: Every 3 months within the 1st year and every 6 months ]
• Transition rate to secondary therapy for eradication of Helicobacter pylori [ Time Frame: Every 6 months within the 1st year and every 12 months as needed ]

Original Primary Outcome:

• • Response rate of gastric low-grade MALT lymphoma by eradication of Helicobacter pylori [ Time Frame: Every 3 months within the 1st year and every 6 months ]
• • Transition rate to secondary therapy for eradication of Helicobacter pylori [ Time Frame: Every 6 months within the 1st year and every 12 months as needed ]

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Eisai Inc.

Dates:
Date Received: December 20, 2010
Date Started: January 13, 2011
Date Completion:
Last Updated: February 23, 2017
Last Verified: January 2017